In context: Intel Core Ultra 200 desktop processors failed to impress some reviewers (including us) when they launched last October as the company's new flagship Arrow Lake-S lineup. While they ...

Recently exposed manifests reveal that Intel has begun shipping test samples of its next-generation server and desktop processors. While much about these upcoming CPUs remains uncertain ...

SemiAccurate said it was read an email about a company trying to acquire all of Intel (INTC), reports Charlie Demerjian. “We have absolute faith in the accuracy of this email but it took months ...

Following SemiAccurate’s article about a takeout speculation of Intel (INTC), Citi says the most likely company interested in a wholesale takeout of Intel would be Broadcom (AVGO). Citi would ...

Intel revenues dropped from $79 billion in 2021 to $54 billion in 2023 as CPU sales declined due to the cooling off of the PC market post-Covid-19 and also due to market share gains by rival AMD ...

2025 will be a pivotal year for chip-giant Intel (NASDAQ: INTC) as it navigates an industry that it no longer dominates. A multiyear turnaround effort led by former CEO Pat Gelsinger, which aimed ...

Intel needs a new CEO as it enters a critical year. The Intel 18A process must launch on time without any major problems. Intel's product roadmap depends on Intel 18A, as does its foundry business ...

You may think you know how much Intel is struggling, but the reality is worse. The once-mighty American innovation powerhouse is losing market share in multiple areas that are critical to its ...

Here are the prospects who stood out and some early recruiting intel on several of the nation's top recruits: ...

Neil is a freelance tech journalist with 20 years of experience in IT. He’s the host of the popular Tech Talks Daily Podcast, picking up… A month later, underfire Intel CEO Pat Gelsinger revealed an ...

The most common brand of processor in laptops you can buy in the UK is Intel. However, Intel's myriad of marketing names for its various processors can make comparisons extremely tricky. In this guide ...

A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products.